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Abstract A growing body of evidence suggests that mito-
chondrial dysfunctions play a crucial role in the pathogenesis
of various neurodegenerative disorders, including amyotro-
phic lateral sclerosis (ALS), a neurodegenerative disease
affecting both upper and lower motor neurons. Although
ALS is predominantly a sporadic disease, approximately 10%
of cases are familial. The most frequent familial form is
caused by mutations in the gene encoding Cu/Zn superoxide
dismutase 1 (SOD1). A dominant toxic gain of function of
mutant SOD1 has been considered as the cause of the disease
and mitochondria are thought to be key players in the
pathogenesis. However, the exact nature of the link between
mutant SOD1 and mitochondrial dysfunctions remains to be
established. Here, we briefly review the evidence for mito-
chondrial dysfunctions in familial ALS and discuss a possible
link between mutant SOD1 and mitochondrial dysfunction.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive disease
characterized by the loss of upper and lower motor neurons. In
most ALS cases there is no clear genetic linkage (sporadic
ALS) but in approximately 10% of ALS patients the disease is
inherited (familial ALS). About 20% of these familial ALS
cases are caused by autosomal dominant mutations in the gene
encoding Cu/Zn superoxide dismutase 1 (SOD1) (Rosen et al.
1993; reviewed in Cleveland and Rothstein 2001; Pasinelli
and Brown 2006; Turner and Talbot 2008). This enzyme
mediates the conversion of superoxide anions, mainly
generated during oxidative phosphorylation, into hydrogen
peroxide, an indispensible defense mechanism against
reactive oxygen species (ROS). To date, over 140 different
mutations in the SOD1 gene have been identified (http://
alsod.iop.kcl.ac.uk/Als/Summary/summary.aspx). Since loss
of SOD1 activity does not always result from these
mutations (Borchelt et al. 1994; Bowling et al. 1995) and
SOD1 knockout mice show no overt motor deficits (Reaume
et al. 1996), it is now widely accepted that these mutations
cause SOD1 to gain a toxic property. Several mechanisms
for this toxicity have been proposed including mitochondrial
dysfunctions, oxidative stress, Ca2+ dysregulation, aggrega-
tion of aberrantly processed proteins, endoplasmic reticulum
(ER) stress, axonal transport disruption, glutamate excito-
toxicity, apoptosis and inflammation (reviewed in Barber and
Shaw 2010; Boillee et al. 2006; Duffy et al. 2011;
Grosskreutz et al. 2010; Hervias et al. 2006; Manfredi and
Xu 2005). The pathogenicity of SOD1 mutations therefore
appears to reflect a combination of different mechanisms
acting together or consecutively and ultimately leading to
cell death. Dissecting out the relative significance of each
mechanism remains challenging. Here, we briefly review
mitochondrial dysfunction as a possible determining factor in
the pathogenesis of familial ALS.
Mitochondrial morphological abnormalities
and dysfunctions in familial ALS
Mitochondrial functions can be directly or indirectly linked
to most, if not all, of the postulated causal mechanisms
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involved in ALS including dysregulation of intracellular
Ca2+ homeostasis, oxidative stress, glutamate excitotoxicity,
apoptosis and axonal transport disruption. Therefore, mito-
chondria can be considered as a convergence point in motor
neuron degeneration. Mitochondrial damage has been well
documented in both sporadic and familial ALS. The first
evidence of mitochondrial abnormalities came from ultra-
structural studies showing aggregates of mitochondria in
muscles and spinal cord motor neurons (Sasaki and Iwata
1996) and increased mitochondrial volume in motor nerve
terminals of ALS patients (Siklos et al. 1996). Consistent
with these findings, observations of mitochondrial morpholo-
gy in cell or animal models of familial ALS showed
aggregated, swollen, vacuolated or fragmented mitochondria
(Bendotti et al. 2001; Coussee et al. 2011; Damiano et al.
2006; Jaarsma et al. 2001; Jung et al. 2002; Menzies et al.
2002; Raimondi et al. 2006; Xu et al. 2004).
Several lines of evidence further indicate that these
mitochondrial morphology changes are tightly associated
with mitochondrial dysfunctions. Changes in the activity of
the different complexes of the electron transport chain have
been described in tissues obtained from ALS patients, and
in cell and animal disease models. Although some of these
studies have produced mixed and somewhat contradictory
results, the most consistent abnormality in mitochondrial
respiratory function has been associated with reduced
complex I and IV activity (Browne et al. 1998; Kirkinezos
et al. 2005; Mattiazzi et al. 2002; Menzies et al. 2002;
Rizzardini et al. 2006; Son et al. 2008). In motor neurons of
mutant SOD1G93A mice a reduction in activity of complex I
was observed before disease onset and progressing to
inhibition of complex IV at later stages (Jung et al. 2002).
In neuroblastoma cells overexpressing mutant SOD1G37R,
we observed a decreased activity of complex I in
mitochondrial fractions (Coussee et al. 2011). This reduction
was not related to a lower expression level of complex I.
The maintenance of the mitochondrial membrane poten-
tial is reliant on the activity of the different complexes of
the electron transport chain. Consistent with this, mito-
chondrial depolarization has been observed in neuroblasto-
ma cells expressing mutant SOD1G93A (Carri et al. 1997) or
SOD1G37R (Coussee et al. 2011) and in motor neurons from
mutant SOD1G93A mice (Kruman et al. 1999). Stimulation-
induced mitochondrial membrane depolarizations in motor
terminals of G93A and G85R transgenic mice were
significantly enhanced and increased the likelihood of
mitochondrial permeability transition pore opening during
mitochondrial Ca2+ uptake (Nguyen et al. 2011; Nguyen et
al. 2009).
Another set of observations, providing further evidence for
mitochondrial dysfunctions in the pathogenesis of familial
ALS include impaired ATP synthesis and reduced mitochon-
drial Ca2+ buffering in cells expressing a number of different
SOD1 mutations. For example, ATP generation was markedly
decreased in neuronal cells of mutant SOD1G93A mice
(Browne et al. 2006; Mattiazzi et al. 2002). Cytosolic ATP
levels were significantly reduced in neuroblastoma cells
expressing mutant SOD1G37R (Coussee et al. 2011) and
decreased more rapidly and to a greater extent in rotenone-
treated SOD1G93A neuronal cells (Rizzardini et al. 2006).
Impairment of intracellular Ca2+ homeostasis has been
reported in cells expressing mutant SOD1G93A or SOD1G37R
(Carri et al. 1997; Coussee et al. 2011; Tradewell et al. 2011)
and in motor neurons from mutant SOD1G93A transgenic
mice (Jaiswal and Keller 2009; Jaiswal et al. 2009; Kruman
et al. 1999). Also isolated mitochondria from transgenic
mutant SOD1G93A and SOD1G85R mice showed a significant
decrease in Ca2+ loading capacity (Damiano et al. 2006;
Nguyen et al. 2009; Vila et al. 2003). ATP deficit and Ca2+
dysregulation may arise secondary to mutant SOD1-induced
impairment of oxidative phosphorylation, or as a direct
consequence of mutant SOD1 impeding on mitochondrial
transport of ions and metabolites.
Finally, numerous studies have found evidence of
increased oxidative and/or nitrosative stress in ALS
pathogenesis. Transgenic mouse models of ALS expressing
mutant human SOD1 support human studies showing
increased oxidative damage to mitochondrial proteins,
lipids and DNA (reviewed in Barber and Shaw 2010). This
has been explained by excessive dismutase activity of
mutant SOD1 (Goldsteins et al. 2008; Wiedau-Pazos et al.
1996), increased levels of ROS produced by mitochondria
following inhibition of complex I (Kruman et al. 1999;
Mattiazzi et al. 2002; Murphy 2009; Zimmerman et al.
2007), or increased NADPH oxidase (NOX) activity
through mutant SOD1 interacting with Rac1, a NOX
regulator (reviewed in Boillee and Cleveland 2008). It
should be noted, however, that recent data indicate that
overexpression of mutant SOD1G93A in yeast cells actually
provided increased protection against respiration-derived
ROS (Kloppel et al. 2010).
Despite the clear evidence that mutant SOD1 induces a
fundamental impairment in energy metabolism mecha-
nisms, Ca2+ homeostasis and ROS handling, the exact
cause and effect remain unclear. A number of potential
scenarios exist. Of particular interest is the observation that
mutant SOD1 preferentially accumulates at the cytoplasmic
face of the outer membrane and in the intermembrane space
of mitochondria (Cozzolino et al. 2009; Ferri et al. 2006;
Higgins et al. 2003; Sotelo-Silveira et al. 2009). Therefore,
it is possible that an aberrant association between mutant
SOD1 and mitochondrial proteins may lead to impaired
electron transport chain functioning, shortage of ATP,
increased ROS formation and Ca2+ dysregulation.
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Mutant SOD1 may affect ER-mitochondrial coupling
One way how mislocalized mutant SOD1 could affect
mitochondrial functions is through direct interaction with
outer mitochondrial membrane proteins. Mutant SOD1 has
been shown to associate with Lysyl-tRNA synthetase
(Kawamata et al. 2008), an enzyme required for mitDNA-
encoded protein translation, members of the Bcl-2 family of
proteins (Arbel and Shoshan-Barmatz 2010) and the
voltage-dependent anion channel VDAC1 (Israelson et al.
2010). The binding of mutant SOD1 to VDAC1 deserves
further attention. VDAC1 is a multifunctional mitochondrial
protein involved in the transport of ions and small molecules
including Ca2+, ATP/ADP and NADH, across the mitochon-
drial outer membrane (reviewed in Colombini 2004;
Pedersen 2008; Shoshan-Barmatz and Ben-Hail 2011;
Shoshan-Barmatz et al. 2010). Changes in the transport rate
of these ions and molecules will affect mitochondrial and
cellular metabolism, positioning VDAC1 at a key position in
the cellular energy metabolism. VDAC1 has also been found
in ER membrane fractions, notably at contact sites between
mitochondria and ER, where it may catalyze the uptake of
ATP (Shoshan-Barmatz and Israelson 2005). In addition to
its key role in energy metabolism, VDAC1 also binds to pro-
and anti-apoptotic proteins of the Bcl-2 family, is an essential
component of the permeability transition pore and has
therefore been proposed to be a key player in mitochondria-
mediated apoptosis (reviewed in Shoshan-Barmatz and Ben-
Hail 2011; Shoshan-Barmatz et al. 2010). Furthermore,
VDAC1 interacts with several other mitochondrial and
cytosolic proteins and recent evidence indicates that it may
be part of the physical link between mitochondria and the ER
Ca2+-release channel inositol 1,4,5-trisphosphate receptor
(IP3R) (Szabadkai et al. 2006). This tight coupling between
ER and mitochondria through IP3R-VDAC1 associations not
only allows VDAC1-mediated Ca2+ fluxes to the intermem-
brane space from the high [Ca2+] microdomain created by
activation of IP3Rs but also provides high [ATP] micro-
domains required for subsequent SERCA-mediated Ca2+
reuptake into the ER. It thus seems obvious that even small
changes in the number or distance of these physical contacts
between mitochondria and ER may have profound effects on
mitochondrial and cellular functions. A decrease in the
number of physical contacts between mitochondria and ER
or an increase in their distance would diminish mitochondrial
Ca2+ uptake induced by IP3-mediated Ca
2+ release. Since
mitochondrial oxidative phosphorylation is stimulated at
different levels (three dehydrogenases of the Krebs cycle
and the F1F0 ATP synthase) by Ca
2+ (Jouaville et al. 1999),
reduced mitochondrial Ca2+ uptake would impede ATP
production. For the same reasons, ER-mitochondrial uncou-
pling would limit the generation of [ATP] hot spots. In
addition, the recent finding that mutant SOD1 binding to
VDAC1 reduces VDAC1-mediated ADP transport across the
outer mitochondrial membrane (Israelson et al. 2010) will
further limit ATP synthesis. In all these cases, ATP
generation may thus be seriously hampered that it actually
falls short of cytosolic ATP demand during on-going cellular
activity. Since VDAC1 plays a central role in cellular
metabolism and serves as a mitochondrial-binding site for
other proteins, including mutant SOD1 and IP3Rs, an
appealing hypothesis is that this aberrant interaction of
mutant SOD1 with VDAC1 not only impairs VDAC1-
mediated transport across the mitochondrial outer membrane
Fig. 1 Simplified model for altered mitochondrial Ca2+ uptake and
ATP production in mutant SOD1 cells. Binding of mutant SOD1
(mSOD1) to VDAC1 results in uncoupling of ER/mitochondrial
network leading to diminished mitochondrial Ca2+ uptake, increased
cytosolic Ca2+ transient and lower ATP availability. Dark grey level
corresponds to high Ca2+ content; thick black arrows reflect high Ca2+
flux; thick grey arrows reflect high ATP flux. MU mitochondrial
uniporter; ANT adenine nucleotide transporter
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but also destabilizes VDAC1 binding to IP3Rs. This leads to
a reduction of the number of VDAC1 proteins available for
IP3R coupling and hence impairing the privileged commu-
nication between mitochondria and ER (Fig. 1).
Consistent with this hypothesis, our own findings in N2a
neuroblastoma cells overexpressing mutant SOD1G37R
showed decreased IP3-induced mitochondrial Ca
2+ uptake
in intact cells compared to parental cells (Coussee et al.
2011). IP3-induced mitochondrial Ca
2+ uptake was not
affected in cells overexpressing wild-type SOD1. Ca2+-
induced mitochondrial Ca2+ uptake in permeabilized cells,
which does not rely on ER Ca2+ release or the intimate
coupling between mitochondria and ER, was not affected in
mutant SOD1G37R cells. This finding is also consistent with
the observation that mutant SOD1 does not affect VDAC1-
mediated Ca2+ transfer (Israelson et al. 2010). Cytosolic
ATP levels were also significantly decreased in mutant
SOD1G37R cells resulting in compromised ER Ca2+ uptake
in intact cells while ER Ca2+ uptake in permeabilized cells
provided with sufficient amounts of ATP was not affected.
Our finding that complex I activity is significantly impaired
in mutant SOD1G37R cells may reflect reduced VDAC1
permeability for metabolites necessary for respiration.
Finally, using confocal microscopy, we compared the
distribution of the ER marker Dsred with that of the
mitochondrial marker mit-GFP. A quantitative analysis of
colocalization between the two signals revealed a lower
Mander’s coefficient (Mc) in mutant SOD1G37R cells (Mc
of 0.64) compared to wild-type SOD1 cells (Mc of 0.56)
(unpublished preliminary data). These results suggest a loss
of coupling between mitochondria and ER in mutant
SOD1G37R cells. Further studies will be needed to corrobo-
rate these findings by quantifying Ca2+ hot spots or assessing
VDAC1 localization at ER-mitochondria contact sites in
mutant SOD1G37R cells.
Because mitochondrial Ca2+ uptake during IP3-induced
Ca2+ release was significantly reduced in mutant SOD1G37R
cells, IP3-induced Ca
2+ release led to significant larger
cytosolic Ca2+ signals. Since mutant SOD1G37R expression
had no major effects on the viability of N2a neuroblastoma
cells, the extrapolation of these findings to motor neuron
degeneration appears trivial. However, unlike many other
cell types, motor neurons display low cytosolic Ca2+ buffering
(Grosskreutz et al. 2007; von Lewinski et al. 2008) and
heavily rely on oxidative phosphorylation during on-going
rhythmic activity. It therefore becomes apparent that cytosolic
Ca2+ overloading and ATP shortage in motor neurons carrying
SOD1 mutations are predominant and pose a sustained
metabolic stress on mitochondria, accelerating cellular ageing
and ultimately lowering the threshold for apoptosis.
In summary, the aberrant interaction of mutant SOD1
with VDAC1 may impair VDAC1-mediated transport and
ER-mitochondria coupling resulting in decreased mitochon-
drial Ca2+ uptake and ATP production. This Ca2+ dysregu-
lation and energetic deficit may represent the starting point
for a vicious circle leading to motor neuron degeneration in
familial ALS.
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